We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.48%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$111B
AUM Growth
+$4.45B
(+4.2%)
Cap. Flow
-$1.78B
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
29%
Holding
4,480
New
63
Increased
1,265
Reduced
2,421
Closed
236
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$46M |
| 2 |
Palantir
PLTR
|
+$40.3M |
| 3 |
SW
Smurfit Westrock
SW
|
+$39.2M |
| 4 |
Dell
DELL
|
+$29.2M |
| 5 |
Avantor
AVTR
|
+$27.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$97.8M |
| 2 |
Eli Lilly
LLY
|
+$58.2M |
| 3 |
NVIDIA
NVDA
|
+$48.6M |
| 4 |
ExxonMobil
XOM
|
+$31.3M |
| 5 |
Bank of America
BAC
|
+$30.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.19% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 11.38% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Industrials | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Phibro Animal Health
PAHC
$1.39B
| $1.71M | ﹤0.01% |
76,098
-5,129
| -6% | -$99K |
|
1977
KE Holdings
BEKE
$18.8B
| $1.71M | ﹤0.01% |
86,046
-18,362
| -18% | -$271K |
|
1978
Janux Therapeutics
JANX
$967M
| $1.71M | ﹤0.01% |
37,554
-454
| -1% | -$19.8K |
|
1979
Shoals Technologies Group
SHLS
$1.5B
| $1.7M | ﹤0.01% |
303,875
-14,825
| -5% | -$88.6K |
|
1980
Leslie's
LESL
$11M
| $1.7M | ﹤0.01% |
26,831
-330
| -1% | -$20.4K |
|
1981
Insteel Industries
IIIN
$625M
| $1.69M | ﹤0.01% |
54,511
-21,297
| -28% | -$681K |
|
1982
iShares MSCI China A ETF
CNYA
$208M
| $1.69M | ﹤0.01% |
55,660
| – | – |
|
1983
Ennis
EBF
$564M
| $1.68M | ﹤0.01% |
69,281
-5,864
| -8% | -$136K |
|
1984
Liberty Broadband Class A
LBRDA
$5.16B
| $1.68M | ﹤0.01% |
21,909
-11,660
| -35% | -$710K |
|
1985
Enact Holdings
ACT
$6.73B
| $1.67M | ﹤0.01% |
45,903
-4,247
| -8% | -$145K |
|
|
ADAM
1986
Adamas Trust
ADAM
$883M
| $1.66M | ﹤0.01% |
263,019
-11,002
| -4% | -$70.8K |
|
1987
Travere Therapeutics
TVTX
$5.78B
| $1.66M | ﹤0.01% |
118,608
-7,052
| -6% | -$73.5K |
|
1988
TriMas Corp
TRS
$1.44B
| $1.65M | ﹤0.01% |
64,817
-4,511
| -7% | -$113K |
|
1989
Vital Farms
VITL
$525M
| $1.65M | ﹤0.01% |
47,151
-14
| -0% | -$495 |
|
|
FLNA
1990
Filana Therapeutics
FLNA
$48.1M
| $1.65M | ﹤0.01% |
56,157
-3,102
| -5% | -$71.4K |
|
1991
Utz Brands
UTZ
$1.25B
| $1.65M | ﹤0.01% |
93,346
-5,940
| -6% | -$98.7K |
|
|
ZUO
1992
DELISTED
Zuora, Inc.
ZUO
| $1.65M | ﹤0.01% |
191,080
-2,843
| -1% | -$25.2K |
|
1993
ING
ING
$102B
| $1.64M | ﹤0.01% |
90,434
+3,860
| +4% | +$69K |
|
|
PLYM
1994
DELISTED
Plymouth Industrial REIT
PLYM
| $1.64M | ﹤0.01% |
72,519
-3,735
| -5% | -$86.8K |
|
|
PGRE
1995
DELISTED
Paramount Group
PGRE
| $1.64M | ﹤0.01% |
333,098
-16,398
| -5% | -$81.2K |
|
|
EVRI
1996
DELISTED
Everi Holdings
EVRI
| $1.64M | ﹤0.01% |
124,466
-671
| -0.5% | -$7.91K |
|
1997
Vale
VALE
$62.6B
| $1.63M | ﹤0.01% |
139,850
-11,541
| -8% | -$124K |
|
1998
Cytek Biosciences
CTKB
$546M
| $1.63M | ﹤0.01% |
294,525
-60,911
| -17% | -$345K |
|
1999
Columbus McKinnon
CMCO
$584M
| $1.63M | ﹤0.01% |
45,222
-1,940
| -4% | -$65.8K |
|
|
GDEN
2000
DELISTED
Golden Entertainment
GDEN
| $1.63M | ﹤0.01% |
51,189
-1,171
| -2% | -$36.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2024 Portfolio in Review
As of Q3 2024, RhumbLine Advisers held 4,480 positions worth $111B, up 4.2% from $106B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
RhumbLine Advisers's Q3 2024 filing shows 63 new, 1,265 increased, 2,421 reduced and 236 closed positions. Its largest new stake was Smurfit Westrock: 860,959 shares worth $42.5M. The largest sale was Microsoft, an estimated $97.8M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2024 buy was Smurfit Westrock: 860,959 shares worth $42.5M.
- RhumbLine Advisers added most to Apple in Q3 2024, an estimated $46M increase.
- RhumbLine Advisers's biggest Q3 2024 reduction was Microsoft, cutting an estimated $97.8M.
- RhumbLine Advisers fully exited Expand Energy Corp in Q3 2024, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 29% of its $111B portfolio in Q3 2024.
- RhumbLine Advisers opened 63 new positions and closed 236 in Q3 2024.
- RhumbLine Advisers's portfolio value rose 4.2% quarter-over-quarter to $111B.
Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.